People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TheraCell, Inc. | — | Biotechnology | Seed | $1.3M | $59.7M | 2009 |
Danny M. Gazit at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Danny M. Gazit on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bradley E. Patt | 1 | 3 |
| Joseph M. Miller | 1 | 2 |
| Jan S. Iwanczyk | 1 | 2 |
| Frank M. Phillips | 1 | 1 |
| Richard K. Grant | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.